APO Research
Talk to an analyst

APO RESEARCH · REPORT

Carbapenem

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Carbapenem Industry Growth and Trends Forecast to 2032

20 December 202598 pages

Choose your research edition.

Industry ResearchCarbapenem Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Carbapenem Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Carbapenem Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Carbapenem Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Carbapenem Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Carbapenem market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Carbapenem is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Carbapenem is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Carbapenem is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Carbapenem include Sun Pharmaceutical Industries, Pfizer, Haibin Pharmaceutical, United Lab, Savior Lifetec, Kopran and HISUN Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Carbapenem market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Carbapenem market size, estimates, and forecasts are presented in terms of sales volume (tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Carbapenem market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Carbapenem.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Carbapenem market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Carbapenem Market by Company

Sun Pharmaceutical Industries

Pfizer

Haibin Pharmaceutical

United Lab

Savior Lifetec

Kopran

HISUN Pharmaceutical

Carbapenem Segment by Type

Doripenem

Meropenem

Panipenem

Imipenem

Others

Carbapenem Segment by Application

Hosptials

Clinics

Others

Carbapenem Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Carbapenem market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Carbapenem and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Carbapenem.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Carbapenem manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Carbapenem in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Doripenem Table 2. Major Company of Meropenem Table 3. Major Company of Panipenem Table 4. Major Company of Imipenem Table 5. Major Company of Others Table 6. Global Carbapenem Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Carbapenem Sales by Type (2021-2026) & (tons) Table 8. Global Carbapenem Sales Market Share in Volume by Type (2021-2026) Table 9. Global Carbapenem Sales by Type (2021-2026) & (US$ Million) Table 10. Global Carbapenem Sales Market Share in Value by Type (2021-2026) Table 11. Global Carbapenem Price by Type (2021-2026) & (US$/kg) Table 12. Global Carbapenem Sales by Type (2027-2032) & (tons) Table 13. Global Carbapenem Sales Market Share in Volume by Type (2027-2032) Table 14. Global Carbapenem Sales by Type (2027-2032) & (US$ Million) Table 15. Global Carbapenem Sales Market Share in Value by Type (2027-2032) Table 16. Global Carbapenem Price by Type (2027-2032) & (US$/kg) Table 17. North America Carbapenem Sales by Type (2021-2026) & (tons) Table 18. North America Carbapenem Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Carbapenem Sales by Type (2021-2026) & (tons) Table 20. Europe Carbapenem Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Carbapenem Sales by Type (2021-2026) & (tons) Table 22. Asia-Pacific Carbapenem Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Carbapenem Sales by Type (2021-2026) & (tons) Table 24. Latin America Carbapenem Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Carbapenem Sales by Type (2021-2026) & (tons) Table 26. Middle East and Africa Carbapenem Sales by Type (2021-2026) & (US$ Million) Table 27. Carbapenem Industry Trends Table 28. Carbapenem Industry Drivers Table 29. Carbapenem Industry Opportunities and Challenges Table 30. Carbapenem Industry Restraints Table 31. Global Carbapenem Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Carbapenem Revenue Market Share by Company (2021-2026) Table 33. Global Carbapenem Sales by Company (2021-2026) & (tons) Table 34. Global Carbapenem Sales Share by Company (2021-2026) Table 35. Global Carbapenem Market Price by Company (2021-2026) & (US$/kg) Table 36. Global Carbapenem Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Carbapenem Major Company Production Sites and Headquarters Table 38. Global Carbapenem Company, Product Type & Application Table 39. Global Carbapenem Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Carbapenem by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Carbapenem Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Carbapenem Sales by Region (2021-2026) & (tons) Table 44. Global Carbapenem Sales Market Share in Volume by Region (2021-2026) Table 45. Global Carbapenem Sales by Region (2021-2026) & (US$ Million) Table 46. Global Carbapenem Sales Market Share in Value by Region (2021-2026) Table 47. Global Carbapenem Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 48. Global Carbapenem Sales by Region (2027-2032) & (tons) Table 49. Global Carbapenem Sales Market Share in Volume by Region (2027-2032) Table 50. Global Carbapenem Sales by Region (2027-2032) & (US$ Million) Table 51. Global Carbapenem Sales Market Share in Value by Region (2027-2032) Table 52. Global Carbapenem Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2027-2032) Table 53. Global Carbapenem Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Carbapenem Sales by Application (2021-2026) & (tons) Table 55. Global Carbapenem Sales Market Share in Volume by Application (2021-2026) Table 56. Global Carbapenem Sales by Application (2021-2026) & (US$ Million) Table 57. Global Carbapenem Sales Market Share in Value by Application (2021-2026) Table 58. Global Carbapenem Price by Application (2021-2026) & (US$/kg) Table 59. Global Carbapenem Sales by Application (2027-2032) & (tons) Table 60. Global Carbapenem Sales Market Share in Volume by Application (2027-2032) Table 61. Global Carbapenem Sales by Application (2027-2032) & (US$ Million) Table 62. Global Carbapenem Sales Market Share in Value by Application (2027-2032) Table 63. Global Carbapenem Price by Application (2027-2032) & (US$/kg) Table 64. North America Carbapenem Sales by Application (2021-2026) & (tons) Table 65. North America Carbapenem Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Carbapenem Sales by Application (2021-2026) & (tons) Table 67. Europe Carbapenem Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Carbapenem Sales by Application (2021-2026) & (tons) Table 69. Asia-Pacific Carbapenem Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Carbapenem Sales by Application (2021-2026) & (tons) Table 71. Latin America Carbapenem Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Carbapenem Sales by Application (2021-2026) & (tons) Table 73. Middle East and Africa Carbapenem Sales by Application (2021-2026) & (US$ Million) Table 74. Sun Pharmaceutical Industries Company Information Table 75. Sun Pharmaceutical Industries Business Overview Table 76. Sun Pharmaceutical Industries Carbapenem Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 77. Sun Pharmaceutical Industries Carbapenem Product Portfolio Table 78. Sun Pharmaceutical Industries Recent Development Table 79. Pfizer Company Information Table 80. Pfizer Business Overview Table 81. Pfizer Carbapenem Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 82. Pfizer Carbapenem Product Portfolio Table 83. Pfizer Recent Development Table 84. Haibin Pharmaceutical Company Information Table 85. Haibin Pharmaceutical Business Overview Table 86. Haibin Pharmaceutical Carbapenem Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 87. Haibin Pharmaceutical Carbapenem Product Portfolio Table 88. Haibin Pharmaceutical Recent Development Table 89. United Lab Company Information Table 90. United Lab Business Overview Table 91. United Lab Carbapenem Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 92. United Lab Carbapenem Product Portfolio Table 93. United Lab Recent Development Table 94. Savior Lifetec Company Information Table 95. Savior Lifetec Business Overview Table 96. Savior Lifetec Carbapenem Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 97. Savior Lifetec Carbapenem Product Portfolio Table 98. Savior Lifetec Recent Development Table 99. Kopran Company Information Table 100. Kopran Business Overview Table 101. Kopran Carbapenem Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 102. Kopran Carbapenem Product Portfolio Table 103. Kopran Recent Development Table 104. HISUN Pharmaceutical Company Information Table 105. HISUN Pharmaceutical Business Overview Table 106. HISUN Pharmaceutical Carbapenem Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 107. HISUN Pharmaceutical Carbapenem Product Portfolio Table 108. HISUN Pharmaceutical Recent Development Table 109. North America Carbapenem Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 110. North America Carbapenem Sales by Country (2021-2026) & (tons) Table 111. North America Carbapenem Sales Market Share by Country (2021-2026) Table 112. North America Carbapenem Sales Forecast by Country (2027-2032) & (tons) Table 113. North America Carbapenem Sales Market Share Forecast by Country (2027-2032) Table 114. North America Carbapenem Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. North America Carbapenem Market Size by Country (2021-2026) & (US$ Million) Table 116. North America Carbapenem Market Share by Country (2021-2026) Table 117. North America Carbapenem Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. North America Carbapenem Market Share Forecast by Country (2027-2032) Table 119. Europe Carbapenem Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 120. Europe Carbapenem Sales by Country (2021-2026) & (tons) Table 121. Europe Carbapenem Sales Market Share by Country (2021-2026) Table 122. Europe Carbapenem Sales Forecast by Country (2027-2032) & (tons) Table 123. Europe Carbapenem Sales Market Share Forecast by Country (2027-2032) Table 124. Europe Carbapenem Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Europe Carbapenem Market Size by Country (2021-2026) & (US$ Million) Table 126. Europe Carbapenem Market Share by Country (2021-2026) Table 127. Europe Carbapenem Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Europe Carbapenem Market Share Forecast by Country (2027-2032) Table 129. Asia-Pacific Carbapenem Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 130. Asia-Pacific Carbapenem Sales by Country (2021-2026) & (tons) Table 131. Asia-Pacific Carbapenem Sales Market Share by Country (2021-2026) Table 132. Asia-Pacific Carbapenem Sales Forecast by Country (2027-2032) & (tons) Table 133. Asia-Pacific Carbapenem Sales Market Share Forecast by Country (2027-2032) Table 134. Asia-Pacific Carbapenem Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Asia-Pacific Carbapenem Market Size by Country (2021-2026) & (US$ Million) Table 136. Asia-Pacific Carbapenem Market Share by Country (2021-2026) Table 137. Asia-Pacific Carbapenem Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Asia-Pacific Carbapenem Market Share Forecast by Country (2027-2032) Table 139. Latin America Carbapenem Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 140. Latin America Carbapenem Sales by Country (2021-2026) & (tons) Table 141. Latin America Carbapenem Sales Market Share by Country (2021-2026) Table 142. Latin America Carbapenem Sales Forecast by Country (2027-2032) & (tons) Table 143. Latin America Carbapenem Sales Market Share Forecast by Country (2027-2032) Table 144. Latin America Carbapenem Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Latin America Carbapenem Market Size by Country (2021-2026) & (US$ Million) Table 146. Latin America Carbapenem Market Share by Country (2021-2026) Table 147. Latin America Carbapenem Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Latin America Carbapenem Market Share Forecast by Country (2027-2032) Table 149. Middle East and Africa Carbapenem Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 150. Middle East and Africa Carbapenem Sales by Country (2021-2026) & (tons) Table 151. Middle East and Africa Carbapenem Sales Market Share by Country (2021-2026) Table 152. Middle East and Africa Carbapenem Sales Forecast by Country (2027-2032) & (tons) Table 153. Middle East and Africa Carbapenem Sales Market Share Forecast by Country (2027-2032) Table 154. Middle East and Africa Carbapenem Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Middle East and Africa Carbapenem Market Size by Country (2021-2026) & (US$ Million) Table 156. Middle East and Africa Carbapenem Market Share by Country (2021-2026) Table 157. Middle East and Africa Carbapenem Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Middle East and Africa Carbapenem Market Share Forecast by Country (2027-2032) Table 159. Key Raw Materials Table 160. Raw Materials Key Suppliers Table 161. Carbapenem Distributors List Table 162. Carbapenem Customers List Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Carbapenem Image Figure 2. Global Carbapenem Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Carbapenem Market Size (2021-2032) & (US$ Million) Figure 4. Global Carbapenem Sales (2021-2032) & (tons) Figure 5. Doripenem Image Figure 6. Global Doripenem Sales YoY Growth (2021-2032) & (tons) Figure 7. Meropenem Image Figure 8. Global Meropenem Sales YoY Growth (2021-2032) & (tons) Figure 9. Panipenem Image Figure 10. Global Panipenem Sales YoY Growth (2021-2032) & (tons) Figure 11. Imipenem Image Figure 12. Global Imipenem Sales YoY Growth (2021-2032) & (tons) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (tons) Figure 15. Global Carbapenem Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Carbapenem Market Share by Type 2025 VS 2032 Figure 17. North America Carbapenem Sales Market Share in Volume by Type in 2025 Figure 18. North America Carbapenem Sales Market Share in Value by Type in 2025 Figure 19. Europe Carbapenem Sales Market Share in Volume by Type in 2025 Figure 20. Europe Carbapenem Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Carbapenem Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Carbapenem Sales Market Share in Value by Type in 2025 Figure 23. Latin America Carbapenem Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Carbapenem Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Carbapenem Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Carbapenem Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Carbapenem Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hosptials Image Figure 30. Global Hosptials Sales YoY Growth (2021-2032) & (tons) Figure 31. Clinics Image Figure 32. Global Clinics Sales YoY Growth (2021-2032) & (tons) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (tons) Figure 35. Global Carbapenem Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Carbapenem Market Share by Application 2025 VS 2032 Figure 37. North America Carbapenem Sales Market Share in Volume by Application in 2025 Figure 38. North America Carbapenem Sales Market Share in Value by Application in 2025 Figure 39. Europe Carbapenem Sales Market Share in Volume by Application in 2025 Figure 40. Europe Carbapenem Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Carbapenem Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Carbapenem Sales Market Share in Value by Application in 2025 Figure 43. Latin America Carbapenem Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Carbapenem Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Carbapenem Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Carbapenem Sales Market Share in Value by Application in 2025 Figure 47. North America Carbapenem Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 48. North America Carbapenem Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Carbapenem Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Carbapenem Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Carbapenem Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 52. Europe Carbapenem Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Carbapenem Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Carbapenem Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Carbapenem Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 56. Asia-Pacific Carbapenem Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Carbapenem Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Carbapenem Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Carbapenem Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 60. Latin America Carbapenem Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Carbapenem Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Carbapenem Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Carbapenem Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 64. Middle East and Africa Carbapenem Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Carbapenem Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Carbapenem Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Carbapenem Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Carbapenem Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Doripenem
  • Meropenem
  • Panipenem
  • Imipenem
  • Others
Applications
  • Hosptials
  • Clinics
  • Others
Companies covered
  • Sun Pharmaceutical Industries
  • Pfizer
  • Haibin Pharmaceutical
  • United Lab
  • Savior Lifetec
  • Kopran
  • HISUN Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Carbapenem Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Carbapenem Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Carbapenem Market by Type
  6. 1.3.1 Doripenem
  7. 1.3.2 Meropenem
  8. 1.3.3 Panipenem
  9. 1.3.4 Imipenem
  10. 1.3.5 Others
  11. 1.4 Global Carbapenem Market Size by Type
  12. 1.4.1 Global Carbapenem Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Carbapenem Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Carbapenem Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Carbapenem Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Carbapenem Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Carbapenem Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Carbapenem Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Carbapenem Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Carbapenem Industry Trends
  2. 2.2 Carbapenem Industry Drivers
  3. 2.3 Carbapenem Industry Opportunities and Challenges
  4. 2.4 Carbapenem Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Carbapenem Revenue (2021-2026)
  2. 3.2 Global Top Players by Carbapenem Sales (2021-2026)
  3. 3.3 Global Top Players by Carbapenem Price (2021-2026)
  4. 3.4 Global Carbapenem Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Carbapenem Major Company Production Sites & Headquarters
  6. 3.6 Global Carbapenem Company, Product Type & Application
  7. 3.7 Global Carbapenem Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Carbapenem Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Carbapenem Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Carbapenem Tier 1, Tier 2, and Tier 3
4 Carbapenem Regional Status and Outlook
  1. 4.1 Global Carbapenem Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Carbapenem Historic Market Size by Region
  3. 4.2.1 Global Carbapenem Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Carbapenem Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Carbapenem Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Carbapenem Forecasted Market Size by Region
  7. 4.3.1 Global Carbapenem Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Carbapenem Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Carbapenem Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Carbapenem by Application
  1. 5.1 Carbapenem Market by Application
  2. 5.1.1 Hosptials
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Carbapenem Market Size by Application
  6. 5.2.1 Global Carbapenem Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Carbapenem Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Carbapenem Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Carbapenem Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Carbapenem Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Carbapenem Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Carbapenem Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Carbapenem Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sun Pharmaceutical Industries
  2. 6.1.1 Sun Pharmaceutical Industries Company Information
  3. 6.1.2 Sun Pharmaceutical Industries Business Overview
  4. 6.1.3 Sun Pharmaceutical Industries Carbapenem Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sun Pharmaceutical Industries Carbapenem Product Portfolio
  6. 6.1.5 Sun Pharmaceutical Industries Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Carbapenem Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Carbapenem Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 Haibin Pharmaceutical
  14. 6.3.1 Haibin Pharmaceutical Company Information
  15. 6.3.2 Haibin Pharmaceutical Business Overview
  16. 6.3.3 Haibin Pharmaceutical Carbapenem Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Haibin Pharmaceutical Carbapenem Product Portfolio
  18. 6.3.5 Haibin Pharmaceutical Recent Developments
  19. 6.4 United Lab
  20. 6.4.1 United Lab Company Information
  21. 6.4.2 United Lab Business Overview
  22. 6.4.3 United Lab Carbapenem Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 United Lab Carbapenem Product Portfolio
  24. 6.4.5 United Lab Recent Developments
  25. 6.5 Savior Lifetec
  26. 6.5.1 Savior Lifetec Company Information
  27. 6.5.2 Savior Lifetec Business Overview
  28. 6.5.3 Savior Lifetec Carbapenem Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Savior Lifetec Carbapenem Product Portfolio
  30. 6.5.5 Savior Lifetec Recent Developments
  31. 6.6 Kopran
  32. 6.6.1 Kopran Company Information
  33. 6.6.2 Kopran Business Overview
  34. 6.6.3 Kopran Carbapenem Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Kopran Carbapenem Product Portfolio
  36. 6.6.5 Kopran Recent Developments
  37. 6.7 HISUN Pharmaceutical
  38. 6.7.1 HISUN Pharmaceutical Company Information
  39. 6.7.2 HISUN Pharmaceutical Business Overview
  40. 6.7.3 HISUN Pharmaceutical Carbapenem Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 HISUN Pharmaceutical Carbapenem Product Portfolio
  42. 6.7.5 HISUN Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Carbapenem Sales by Country
  2. 7.1.1 North America Carbapenem Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Carbapenem Sales by Country (2021-2026)
  4. 7.1.3 North America Carbapenem Sales Forecast by Country (2027-2032)
  5. 7.2 North America Carbapenem Market Size by Country
  6. 7.2.1 North America Carbapenem Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Carbapenem Market Size by Country (2021-2026)
  8. 7.2.3 North America Carbapenem Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Carbapenem Sales by Country
  2. 8.1.1 Europe Carbapenem Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Carbapenem Sales by Country (2021-2026)
  4. 8.1.3 Europe Carbapenem Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Carbapenem Market Size by Country
  6. 8.2.1 Europe Carbapenem Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Carbapenem Market Size by Country (2021-2026)
  8. 8.2.3 Europe Carbapenem Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Carbapenem Sales by Country
  2. 9.1.1 Asia-Pacific Carbapenem Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Carbapenem Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Carbapenem Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Carbapenem Market Size by Country
  6. 9.2.1 Asia-Pacific Carbapenem Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Carbapenem Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Carbapenem Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Carbapenem Sales by Country
  2. 10.1.1 South America Carbapenem Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Carbapenem Sales by Country (2021-2026)
  4. 10.1.3 South America Carbapenem Sales Forecast by Country (2027-2032)
  5. 10.2 South America Carbapenem Market Size by Country
  6. 10.2.1 South America Carbapenem Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Carbapenem Market Size by Country (2021-2026)
  8. 10.2.3 South America Carbapenem Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Carbapenem Sales by Country
  2. 11.1.1 Middle East and Africa Carbapenem Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Carbapenem Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Carbapenem Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Carbapenem Market Size by Country
  6. 11.2.1 Middle East and Africa Carbapenem Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Carbapenem Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Carbapenem Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Carbapenem Value Chain Analysis
  2. 12.1.1 Carbapenem Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Carbapenem Production Mode & Process
  7. 12.2 Carbapenem Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Carbapenem Distributors
  10. 12.2.3 Carbapenem Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst